Next Article in Journal
Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
Next Article in Special Issue
Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives
Previous Article in Journal
A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma
Previous Article in Special Issue
Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer
 
 
Review

Article Versions Notes

Cancers 2019, 11(6), 834; https://doi.org/10.3390/cancers11060834
Action Date Notes Link
article xml file uploaded 17 June 2019 13:23 CEST Original file -
article xml uploaded. 17 June 2019 13:23 CEST Update https://www.mdpi.com/2072-6694/11/6/834/xml
article pdf uploaded. 17 June 2019 13:23 CEST Version of Record https://www.mdpi.com/2072-6694/11/6/834/pdf
article html file updated 17 June 2019 13:25 CEST Original file -
article html file updated 5 July 2019 19:20 CEST Update -
article html file updated 5 July 2019 19:20 CEST Update -
article html file updated 22 October 2019 00:58 CEST Update -
article html file updated 12 February 2020 20:15 CET Update -
article html file updated 20 July 2022 15:27 CEST Update https://www.mdpi.com/2072-6694/11/6/834/html
Back to TopTop